| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| Gene symbol | PDCD1 | Synonyms | CD279, PD-1, PD1, SLEB2, hPD-1, hPD-l, hSLE1 | Type of gene | protein-coding |
| Chromosome | 2 | Map location | 2q37.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | programmed cell death 1 | ||||
| GTO ID | GTC2250 |
| Trial ID | NCT04163302 |
| Disease | B-Cell Lymphoma |
| Altered gene | CD19|PD1 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19/PD1 CAR-T cells |
| Phase | Phase2 |
| Recruitment status | Unknown |
| Title | Safety and Efficiency Study of CD19-PD1-CART Cell in Relapsed/Refractory B Cell Lymphoma |
| Year | 2019 |
| Country | China |
| Company sponsor | Chinese PLA General Hospital |
| Other ID(s) | HNYY-XYK-02 |
| Cohort 1 | |||||||||
|
|||||||||